Sialic acid: a novel marker of cardiovascular disease?

Karina P Gopaul1, Martin A Crook

  • 1Guy's, King's, and St. Thomas' Hospitals School of Medicine, King's College London, London, UK.

Clinical Biochemistry
|April 21, 2006
PubMed

Insights

Serum total sialic acid (TSA) may indicate cardiovascular disease (CVD) risk. While linked to mortality, its role in atherosclerosis severity and inflammation requires further investigation, with ethnic variations noted.

Area of Science:

  • Biochemistry
  • Epidemiology
  • Cardiovascular Medicine

Background:

  • Cardiovascular disease (CVD) poses a significant global health burden.
  • Emerging research suggests sialic acid (SA) may be a potential risk factor for CVD.
  • Existing studies show mixed results regarding the association between serum TSA and atherosclerosis severity.

Purpose of the Study:

  • To review current methods for determining serum TSA.
  • To evaluate evidence supporting serum TSA as a CVD risk factor.
  • To examine potential mechanisms and the role of serum TSA in atherosclerotic disease.

Main Methods:

  • Literature review of epidemiological and clinical studies.
  • Analysis of data on serum TSA determination methods.
  • Examination of proposed biological mechanisms.

Main Results:

  • Large-scale surveys indicate a positive association between serum TSA and mortality from coronary artery disease (CAD) and stroke.
  • Clinical studies suggest serum TSA acts as a marker of sustained inflammation in CVD, not a direct cause.
  • Evidence for serum TSA as a direct risk factor for atherosclerosis severity is conflicting, with noted ethnic variations.

Conclusions:

  • Serum TSA may serve as a marker for inflammatory responses in CVD.
  • Further research is needed to clarify the causal role of serum TSA in CVD and atherosclerosis.
  • Understanding ethnic variations in TSA is crucial for accurate risk assessment.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...